Quality of Life (QoL) of Long-Term Survivors of Recurrent Central Nervous System (CNS) Germ Cell Tumors (GCT).
Clinical Oncology · 2026-09 · 57 · 104247
DOI: 10.1016/j.clon.2026.104247 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Oncology, 2026-09. Verfasst von J.L. Finlay und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Finlay, J., Gardner, S., Banks, J., Pauley, M., Hastings, C., Osorio, D., Nghiemphu, L., Valiakhmetova, A., Diez, B., Allen, J., & Sands, S. (2026). Quality of Life (QoL) of Long-Term Survivors of Recurrent Central Nervous System (CNS) Germ Cell Tumors (GCT). Clinical Oncology, 57, 104247. https://doi.org/10.1016/j.clon.2026.104247
Vancouver
Finlay J, Gardner S, Banks J, Pauley M, Hastings C, Osorio D, et al. Quality of Life (QoL) of Long-Term Survivors of Recurrent Central Nervous System (CNS) Germ Cell Tumors (GCT). Clinical Oncology. 2026;57:104247. doi:10.1016/j.clon.2026.104247
BibTeX
@article{Finlay2026,
author = {Finlay, J.L. and Gardner, S. and Banks, J. and Pauley, M. and Hastings, C. and Osorio, D. and Nghiemphu, L. and Valiakhmetova, A. and Diez, B. and Allen, J. and Sands, S.A.},
title = {Quality of Life (QoL) of Long-Term Survivors of Recurrent Central Nervous System (CNS) Germ Cell Tumors (GCT)},
journal = {Clinical Oncology},
year = {2026},
volume = {57},
pages = {104247},
doi = {10.1016/j.clon.2026.104247}
}
EUVIMED